Sorafenib Recruiting Phase 2 Trials for Cancer of the Gallbladder / Cholangiocarcinoma of the Extrahepatic Bile Duct Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02836847Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma